HALO
Price
$61.45
Change
+$0.47 (+0.77%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
7.51B
63 days until earnings call
IDYA
Price
$17.54
Change
-$0.92 (-4.98%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
1.62B
63 days until earnings call
Ad is loading...

HALO vs IDYA

Header iconHALO vs IDYA Comparison
Open Charts HALO vs IDYABanner chart's image
Halozyme Therapeutics
Price$61.45
Change+$0.47 (+0.77%)
Volume$19.48K
Capitalization7.51B
IDEAYA Biosciences
Price$17.54
Change-$0.92 (-4.98%)
Volume$18.08K
Capitalization1.62B
HALO vs IDYA Comparison Chart
Loading...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HALO vs. IDYA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a StrongBuy and IDYA is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (HALO: $60.98 vs. IDYA: $18.46)
Brand notoriety: HALO and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 113% vs. IDYA: 94%
Market capitalization -- HALO: $7.51B vs. IDYA: $1.62B
HALO [@Biotechnology] is valued at $7.51B. IDYA’s [@Biotechnology] market capitalization is $1.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 2 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • HALO’s FA Score: 2 green, 3 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, HALO is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • HALO’s TA Score: 5 bullish, 4 bearish.
  • IDYA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both HALO and IDYA are a good buy in the short-term.

Price Growth

HALO (@Biotechnology) experienced а +3.09% price change this week, while IDYA (@Biotechnology) price change was -10.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

HALO is expected to report earnings on May 13, 2025.

IDYA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.51B) has a higher market cap than IDYA($1.62B). HALO YTD gains are higher at: 27.547 vs. IDYA (-28.171). HALO has higher annual earnings (EBITDA): 580M vs. IDYA (-220.54M). IDYA has more cash in the bank: 920M vs. HALO (666M). IDYA has less debt than HALO: IDYA (18.8M) vs HALO (1.5B). HALO has higher revenues than IDYA: HALO (947M) vs IDYA (3.92M).
HALOIDYAHALO / IDYA
Capitalization7.51B1.62B465%
EBITDA580M-220.54M-263%
Gain YTD27.547-28.171-98%
P/E Ratio17.92N/A-
Revenue947M3.92M24,146%
Total Cash666M920M72%
Total Debt1.5B18.8M8,000%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
21
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HALOIDYA
RSI
ODDS (%)
Bearish Trend 4 days ago
52%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 18 days ago
77%
Declines
ODDS (%)
Bearish Trend 12 days ago
68%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
75%
Aroon
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Ad is loading...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VEUPX174.532.33
+1.35%
Vanguard European Stock Instl Plus
EIUTX16.040.15
+0.94%
Eaton Vance Dividend Builder I
AIWCX12.200.07
+0.58%
American Century International Gr C
NWXVX9.660.05
+0.52%
Nationwide International Sm Cp Instl Svc
EGWCX9.51-0.01
-0.11%
Allspring Discovery Small Cap Gr C

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-3.20%
GRI - IDYA
54%
Loosely correlated
-3.26%
KRYS - IDYA
49%
Loosely correlated
+0.56%
IMNM - IDYA
48%
Loosely correlated
+1.30%
PRME - IDYA
47%
Loosely correlated
+4.35%
RCKT - IDYA
47%
Loosely correlated
-2.45%
More